Palatin Technologies, Inc. (PTN)
5.52
-0.47
(-7.85%)
USD |
NASDAQ |
Oct 20, 16:00
5.60
+0.08
(+1.45%)
After-Hours: 20:00
Palatin Technologies Debt to Equity Ratio : 0.0335 for June 30, 2026
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0335 |
| March 31, 2026 | 0.0271 |
| December 31, 2025 | 0.0304 |
| September 30, 2025 | 0.334 |
| June 30, 2025 | -0.0343 |
| March 31, 2025 | -0.0411 |
| December 31, 2024 | -0.0561 |
| September 30, 2024 | -0.0612 |
| June 30, 2024 | -5.294 |
| March 31, 2024 | 0.4475 |
| December 31, 2023 | -0.0722 |
| September 30, 2023 | -0.1911 |
| June 30, 2023 | -0.5307 |
| March 31, 2023 | 0.0834 |
| December 31, 2022 | 0.0563 |
| September 30, 2022 | 0.1228 |
| June 30, 2022 | 0.0709 |
| March 31, 2022 | 0.0451 |
| December 31, 2021 | 0.0392 |
| September 30, 2021 | 0.0271 |
| June 30, 2021 | 0.0252 |
| March 31, 2021 | 0.0212 |
| December 31, 2020 | 0.0165 |
| September 30, 2020 | 0.0155 |
| June 30, 2020 | 0.0158 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.0033 |
| March 31, 2019 | 0.0827 |
| December 31, 2018 | 0.1098 |
| September 30, 2018 | 0.171 |
| June 30, 2018 | 0.233 |
| March 31, 2018 | 0.8067 |
| December 31, 2017 | 1.061 |
| September 30, 2017 | 2.036 |
| June 30, 2017 | -2.734 |
| March 31, 2017 | -0.8518 |
| December 31, 2016 | -1.107 |
| September 30, 2016 | -0.8544 |
| June 30, 2016 | -1.121 |
| March 31, 2016 | -4.189 |
| December 31, 2015 | 2.626 |
| September 30, 2015 | 0.968 |
| June 30, 2015 | 0.807 |
| March 31, 2015 | 0.4099 |
| December 31, 2014 | 0.3004 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.0001 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.0565 |
| Alnylam Pharmaceuticals, Inc. | 2.206 |
| Anika Therapeutics, Inc. | 0.1839 |
| Savara, Inc. | 0.2117 |
| Vericel Corp. | 0.2556 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 8.524M |
| Total Liabilities (Quarterly) | 1.837M |
| Shareholders Equity (Quarterly) | 6.686M |
| Current Ratio | 4.608 |
| Net Debt Paydown Yield | 0.04% |